MHC class I and II expression and induction in oligodendrocytes varies with age
Abstract Oligodendroglia expressing major histocompatibility complex (MHC) molecules have become of central interest in multiple sclerosis (MS) research, but their role in aging is still being elucidated. Using MHC class I and II reporter mice, we compared oligodendroglial MHC expression in neonatal...
Saved in:
| Main Authors: | Riley B. Catenacci, Danny Galleguillos, Adriana Rhodes, Sloan Phillips, Peter A. Calabresi |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-05-01
|
| Series: | Scientific Reports |
| Online Access: | https://doi.org/10.1038/s41598-025-03089-2 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pharmacological modulation of inflammatory oligodendrocyte progenitor cells using three multiple sclerosis disease modifying therapies in vitro
by: Larissa Jank, et al.
Published: (2024-07-01) -
MHC class II-mediated spontaneous rejection of breast carcinomas expressing model neoantigens
by: James William Jenkins, et al.
Published: (2025-04-01) -
Canine intestinal organoids as a platform for studying MHC class II expression in epithelial cells
by: Meg Nakazawa, et al.
Published: (2025-04-01) -
Model for the peptide-free conformation of class II MHC proteins.
by: Corrie A Painter, et al.
Published: (2008-06-01) -
Design of Peptide Immunotherapies for MHC Class-II-Associated Autoimmune Disorders
by: Masha Fridkis-Hareli
Published: (2013-01-01)